June 8, 2025 - 18:31

Canada has made quantum technology a core focus of its 2025 G7 agenda, positioning it as a strategic tool for innovation and economic growth. This initiative highlights the nation's commitment to advancing research and development in the rapidly evolving field of quantum computing and its various applications. By prioritizing quantum technology, Canada aims to enhance its competitive edge on the global stage while fostering collaboration among G7 member countries.
The decision to spotlight quantum technology reflects the increasing recognition of its potential to revolutionize industries such as cybersecurity, pharmaceuticals, and artificial intelligence. As nations race to harness the power of quantum computing, Canada is taking proactive steps to ensure it remains at the forefront of this technological revolution.
Furthermore, Canada plans to engage in partnerships with both public and private sectors to accelerate advancements in quantum research. This collaborative approach is expected to drive innovation, create jobs, and contribute to a sustainable economic future, ultimately benefiting all G7 nations involved.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...